306 related articles for article (PubMed ID: 28527158)
1. Asymptomatic Cryptococcal Antigenemia in People Living with HIV (PLHIV) with Severe Immunosuppression: Is Routine CrAg Screening Indicated in India?
Anuradha S; H AN; Dewan R; Kaur R; Rajeshwari K
J Assoc Physicians India; 2017 Apr; 65(4):14-17. PubMed ID: 28527158
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, India.
Kadam D; Chandanwale A; Bharadwaj R; Nevrekar N; Joshi S; Patil S; Gupte N; Sangle S; Chopade K; Kulkarni V; Balasubramanian U; Suryavanshi N; Jain D; Kanade S; Dharmashale S; Kagal A; Gupta A; Mave V
Indian J Med Microbiol; 2017; 35(1):105-108. PubMed ID: 28303828
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm
Wykowski J; Galagan SR; Govere S; Wallis CL; Moosa MY; Celum C; Drain PK
BMC Infect Dis; 2020 Jan; 20(1):61. PubMed ID: 31959112
[TBL] [Abstract][Full Text] [Related]
4. Laboratory Reflex and Clinic-Based Point-of-Care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality Among People Living With HIV.
Drain PK; Galagan SR; Govere S; Krows M; Thulare H; Wallis CL; Gosnell BI; Moosa MY; Celum C; Bassett IV
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1205-1213. PubMed ID: 33990495
[TBL] [Abstract][Full Text] [Related]
5. Screening for cryptococcal antigen in asymptomatic people with HIV: urgent need in Eastern India.
Chakravarty J; Reddy S; Gupta MK; Tilak R; Diwaker C; Sundar S
AIDS; 2023 Dec; 37(15):2359-2363. PubMed ID: 37650766
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcal antigenemia in anti-retroviral naïve AIDS patients: prevalence and its association with CD4 cell count.
Osazuwa OF; Dirisu O; Okuonghae E
Acta Med Iran; 2012; 50(5):344-7. PubMed ID: 22837089
[TBL] [Abstract][Full Text] [Related]
10. Prospective cohort of AIDS patients screened for cryptococcal antigenaemia, pre-emptively treated and followed in Brazil.
Borges MASB; de Araújo Filho JA; Oliveira BJS; Moreira IS; de Paula VV; de Bastos AL; Soares RBA; Turchi MD
PLoS One; 2019; 14(7):e0219928. PubMed ID: 31344140
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
[TBL] [Abstract][Full Text] [Related]
12. Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.
Sawadogo S; Makumbi B; Purfield A; Ndjavera C; Mutandi G; Maher A; Kaindjee-Tjituka F; Kaplan JE; Park BJ; Lowrance DW
PLoS One; 2016; 11(10):e0161830. PubMed ID: 27760140
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
[TBL] [Abstract][Full Text] [Related]
14. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
Ford N; Shubber Z; Jarvis JN; Chiller T; Greene G; Migone C; Vitoria M; Doherty M; Meintjes G
Clin Infect Dis; 2018 Mar; 66(suppl_2):S152-S159. PubMed ID: 29514236
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcal antigenemia in people living with HIV and AIDS.
Ahuja J; Soneja M; Wig N; Biswas A; Xess I; Singh G; Vibha D; Nischal N
Int J STD AIDS; 2023 Feb; 34(2):130-136. PubMed ID: 36426734
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study.
Bhati R; Pramendra S; Sejoo B; Kumar D; Bohra GK; Meena DS; Verma D; Midha NK
Curr HIV Res; 2021; 19(1):35-39. PubMed ID: 32860359
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda.
Ramachandran A; Manabe Y; Rajasingham R; Shah M
BMC Infect Dis; 2017 Mar; 17(1):225. PubMed ID: 28335769
[TBL] [Abstract][Full Text] [Related]
20. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
Chen J; Zhang R; Shen Y; Liu L; Qi T; Wang Z; Mehraj V; Routy JP; Lu H
HIV Med; 2019 Jan; 20(1):69-73. PubMed ID: 30311440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]